Evolutionary history of the cancer immunity antigen MAGE gene family

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Katsura, Yukako ^a   Satta, Yoko ^a  

^a GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; MELANOMA ANTIGEN; MELANOMA ANTIGEN A; MELANOMA ANTIGEN C; MELANOMA ANTIGEN D; UNCLASSIFIED DRUG; NUCLEOTIDE; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CERCOPITHECIDAE; CONTROLLED STUDY; CONVERGENT EVOLUTION; DNA SEQUENCE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE IDENTIFICATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MELANOMA ANTIGEN A GENE; MELANOMA ANTIGEN C GENE; MELANOMA ANTIGEN D GENE; MELANOMA ANTIGEN GENE; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PLESIOMORPHY; RETROPOSON; SEQUENCE ANALYSIS; TUMOR GENE; X CHROMOSOME; ANIMAL; EXON; GENE CONVERSION; GENE REARRANGEMENT; GENETIC MARKER; GENETICS; HUMAN GENOME; IMMUNITY; IMMUNOLOGY; INVERTED REPEAT; MAMMAL; MULTIGENE FAMILY; NEOPLASM; OPEN READING FRAME; PHYLOGENY; SYNTENY;

CATARRHINI; CERCOPITHECIDAE; EUTHERIA; MAMMALIA;

ANIMALS; ANTIGENS, NEOPLASM; EVOLUTION, MOLECULAR; EXONS; GENE CONVERSION; GENE DUPLICATION; GENE REARRANGEMENT; GENETIC MARKERS; GENOME, HUMAN; HUMANS; IMMUNITY; INVERTED REPEAT SEQUENCES; MAMMALS; MULTIGENE FAMILY; NEOPLASMS; NUCLEOTIDES; OPEN READING FRAMES; PHYLOGENY; SYNTENY;

EID: 79958714832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020365     Document Type: Article

References (68)

1. Nei M, Gu X, Sitnikova T, (1997) Evolution by the birth-and-death process in multigene families of the vertebrate immune system. Proc Natl Acad Sci USA 94: 7799-7806.
2. Nei M, Rooney A, (2005) Concerted and birth-and-death evolution of multigene families. Annu Rev Genet 39: 121-152.
3. Warburton PE, Giordano J, Cheung F, Gelfand Y, Beoson G, (2004) Inverted repeat structure of the human genome: The X-chromosome contains a preponderance of large, highly homologous inverted repeats that contain testes genes. Genome Res 14: 1861-1869.
4. van der Bruggen P, Traversari C, Chomez P, Lurquin C, Plaen ED, et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647.
5. Kirkin AF, Dzhandzhugazyan K, Zeuthen J, (1998) The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes. Exp Clin Immunogenet 15: 19-32.
6. Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N, et al. (2000) T-cell recognition of melanoma-associated antigens. J Cell Physiol 182: 323-31.
7. Chomez P, Backer OD, Bertrand M, De Plaen E, Boon T, et al. (2001) An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544-5551.
8. Bischof J, Ekker M, Wevrick R, (2003) A MAGE/NDN-like gene in zebrafish. Dev Dyn 228: 475-479.
9. López-Sánchez N, González-Fernández Z, Niinobe M, Yoshikawa K, Frade J, (2007) Single mage gene in the chicken genome encodes CMage, a protein with functional similarities to mammalian type II Mage proteins. Physiol Genomics 30: 156-171.
10. Põld M, Põld A, Ma HJ, Sjak-Shie NN, Vescio RA, et al. (2000) Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution. Dev Comp Immunol 24: 719-731.
11. Bertrand M, Huijbers I, Chomez P, De Backer O, (2004) Comparative expression analysis of the MAGED genes during embryogenesis and brain development. Dev Dyn 230: 325-334.
12. Klein J, Horejsí V, (1997) Immunology Oxford Blackwell Science.
13. Rammensee H, Falk K, Rötzschke O, (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213-244.
14. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55: 797-810.
15. Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, et al. (1998) Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 58: 743-752.
16. Sonnhammer E, Durbin R, (1995) A dot-matrix program with dynamic threshold control suited for genomic DNA and protein sequence analysis. Gene 167: GC1-10.
17. Ohtsubo Y, Ikeda-Ohtsubo W, Nagata Y, Tsuda M, (2008) GenomeMatcher: A graphical user interface for DNA sequence comparison. BMC Bioinformatics 9: 376.
18. Thompson J, Higgins D, Gibson T, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
19. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
20. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
21. Stamatakis A, Ludwig T, Meier H, (2005) RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456-463.
22. Ronquist F, Huelsenbeck JP, van der Mark P, (2005) MrBayes 3.1. MrBayes website. Available: http://mrbayes.csit.fsu.edu/download.php. Accessed 2011 May 7.
23. Librado P, Rozas J, (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451-1452.
24. Smit AFA, (1996) Origin of interspersed repeats in the human genome. Curr Opin Genet Devel 6: 743-749.
25. Sawyer S, (1989) Statistical tests for detecting gene conversion. Mol Biol Evol 6: 526-538.
26. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367.
27. Tsunoda T, Takagi T, (1999) Estimating transcription factor bindability on DNA. Bioinformatics 15: 622-630.
28. Han MV, Hahn MW, (2009) Identifying parent-daughter relationships among duplicated genes. Pac Symp Biocomput pp. 114-125.
29. Delbridge M, Patel H, Waters P, McMillan D, Marshall Graves J, (2009) Does the human X contain a third evolutionary block? Origin of genes on human Xp11 and Xq28. Genome Res 19: 1350-1360.
30. Artamonova II, Gelfand MS, (2004) Evolution of the exon-intron structure and alternative splicing of the MAGE-A family of Cancer/Testis Antigens. J Mol Evol 59: 620-631.
31. Lin C, Mak S, Meitner PA, Wolf JM, Bluman EM, et al. (2002) Cancer/testis antigen CSAGE is currently expressed with MAGE in chondrosarcoma. Gene 1-2: 269-278.
32. van der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, et al. (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188: 51-64.
33. Marsman M, Jordens I, Griekspoor A, Neefjes J, (2005) Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis. Adv Cancer Res 93: 129-158.
34. Crotzer VL, Blum JS, (2009) Autophagy and its role in MHC-mediated antigen presentation. J Immunol 182: 3335-3341.
35. Nishimura I, Sakoda J, Yoshikawa K, (2008) Drosophila MAGE controls neural precursor proliferation in postembryonic neurogenesis. Neuroscience 154: 572-581.
36. Sugihara K, Sugiyama D, Byrne J, Wolf DP, Lowitz KP, et al. (2007) Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation. Proc Natl Acad Sci USA 104: 3799-3804.
37. Kim T-M, Hong S-J, Rhyu M-G, (2004) Periodic explosive expansion of human retroelements associated with the evolution of the hominoid primates. J Korean Med Sci 19: 177-185.
38. Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, et al. (1997) Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46: 397-408.
39. Caballero O, Chen Y, (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100: 2014-2021.
40. Yu C, Meyer DJ, Campbell GS, Larmer AC, Carter-Su C, et al. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81-83.
41. Winandy S, Wu P, Georgopoulos K, (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
42. Bhowmick B, Satta Y, Takahata N, (2007) The origin and evolution of human ampliconic gene families and ampliconic structure. Genome Res 17: 441-450.
43. Elango N, Lee J, Peng Z, Loh Y, Yi S, (2009) Evolutionary rate variation in Old World monkeys. Biol Lett 5: 405-408.
44. Takahata N, (2001) Humanity from African Naissance to Coming Millennia Johannesburg Firenze University Press, Firenze/ Witwatersrand University Press pp. 299-305.
45. Hasegawa M, Thorne J, Kishino H, (2003) Time scale of eutherian evolution estimated without assuming a constant rate of molecular evolution. Genes Genet Syst 78: 267-283.
46. Satta Y, Hickerson M, Watanabe H, O'hUigin C, Klein J, (2004) Ancestral population sizes and species divergence times in the primate lineage on the basis of intron and BAC end sequences. J Mol Evol 59: 478-487.
47. Brunet M, Guy F, Pilbeam D, Mackaye HT, Likius A, et al. (2002) A new hominid from the Upper Miocene of Chad, Central Africa. Nature 418: 145-151.
48. Sawai H, Kawamoto Y, Takahata N, Satta Y, (2004) Evolutionary relationships of major histocompatibility complex class I genes in simian primates. Genetics 166: 1897-1907.
49. Fedoroff NV, (1979) On spacers. Cell 16: 697-710.
50. Eickbush TH, Eickbush DG, (2007) Finely orchestrated movements: evolution of the ribosomal RNA genes. Genetics 175: 477-485.
51. Fritsch EF, Lawn RM, Maniatis T, (1980) Molecular Cloning and Characterization of the Human/b-Like Globin Gene Cluster. Ceil 19: 959-972.
52. Czelusniak J, Goodman M, Hewett-Emmett D, Weiss ML, Venta PJ, et al. (1982) Phylogenetic origins and adaptive evolution of avian and mammalian hemoglobin genes. Nature 298: 297-300.
53. Pold M, Pold A, Ma HJ, Sjak-Shieb NN, Vescio RA, et al. (2000) Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution. Dev Comp Immunol 24: 719-731.
54. Bredenbeck A, Losch FO, Sharav T, Eichler-Mertens M, Filter M, et al. (2005) Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy. J Immunol 174: 6716-6724.
55. Chianese-Bullock KA, Pressley J, Garbee D, Hibbitts S, Murphy C, et al. (2005) MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma. J Immunol 174: 3080-3086.
56. Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, et al. (1994) Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A 91: 2105-2109.
57. Hillig R, Coulie PG, Stroobant V, Saenger W, Ziegler A, et al. (2001) High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. J Mol Biol 310: 1167-1176.
58. Marturano J, Longhi R, Casorati G, Protti M, (2008) MAGE-A3(161-175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells. Cancer Immunol Immunother 57: 207-215.
59. Graff-Dubois S, Faure O, Gross DA, Alves P, Scardino A, et al. (2002) Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1,-A2,-A3,-A4,-A6,-A10, and-A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy. J Immunol 169: 575-580.
60. Miyahara Y, Naota H, Wang L, Hiasa A, Goto M, et al. (2005) Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Clin Cancer Res 11: 5581-5589.
61. Gotoh M, Takasu H, Harada K, Yamaoka T, (2002) Development of HLA-A2402/K(b) transgenic mice. Int J Cancer 100: 565-570.
62. Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, et al. (2007) Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 120: 337-343.
63. Novellino L, Castelli C, Parmiani G, (2005) A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 54: 187-207.
64. Luescher I, Romero P, Kuznetsov D, Rimoldi D, Coulie P, et al. (1996) HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44. J Biol Chem 271: 12463-12471.
65. Escudier B, Dorval T, Chaput N, André F, Caby MP, et al. (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med 3: 10.
66. Vujanovic L, Mandic M, Olson W, Kirkwood J, Storkus W, (2007) A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6. Clin Cancer Res 13: 6796-6806.
67. Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, et al. (2003) MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. Clin Cancer Res 9: 947-954.
68. Wang X, Cohen WM, Castelli FA, Almunia C, Lethé B, et al. (2007) Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family. Cancer Immunol Immunother 56: 807-818.